Clinical Trial: A Study to Evaluate the Efficacy and Safety of ALN-HSD in Adult Participants With Non-alcoholic Steatohepatitis (NASH) With Fibrosis With Genetic Risk Factors
Study Status: ACTIVE_NOT_RECRUITING
Recruit Status: ACTIVE_NOT_RECRUITING
Condition: Nonalcoholic Steatohepatitis
Study Type: INTERVENTIONAL
Official Title: A Master Protocol of Randomized, Double-Blind, Placebo-Controlled, Phase 2 Studies of siRNA Gene Silencing for the Treatment of Non- Alcoholic Steatohepatitis (NASH) in Participants With Genetic Risk
Brief Summary:
The study is researching an investigational drug called ALN-HSD (called "study drug" in this form).The study is focused on participants who are known to have non-alcoholic steatohepatitis (NASH).NASH is a form of non-alcoholic fatty liver disease (NAFLD).NASH occurs when fat builds up in liver cells, damaging them, and making the liver inflamed and stiff from fibrosis (scar tissue).NASH can progress to cirrhosis (long term scarring) and liver failure (when your liver cannot perform its job).The aim of…
Read more